Remove 2023 Remove Clinical Trials Remove Treatment
article thumbnail

The Cannabis Cancer Connection

Project CBD

Goldstrich, MD, with Angela Bacca (Flower Valley Press, 2023). They conducted a double-blind, placebo-controlled phase 2 clinical trial using Sativex® in conjunction with temozolomide to treat recurrent glioblastoma multiforme (GBM). GW Pharmaceuticals’ research on glioblastoma multiforme (GBM) is important and promising.

article thumbnail

Final Phase of MDMA Clinical Trials Shows Drug Is 90% Effective at Treating PTSD

SpeedWeed

A first-of-its-kind Phase 3 clinical trial has found that MDMA-assisted therapy provided meaningful relief from PTSD symptoms in nearly 90 percent of study participants. For 88% of people who receive this treatment, we can expect to see a treatment response. Image via. View original article.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Which States Are Voting on Psychedelics?

Veriheal

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Smith cited results from clinical trials showing that MDMA holds promise in the treatment of PTSD. Connecticut Gov. Minnesota Rep.

article thumbnail

Is Weed Legal in Japan? Cannabis Legalization Bill Explained

Veriheal

In December of 2023, the country recently made a new move towards reform that could stimulate the cannabidiol (CBD) industry and provide many patients, such as those with epilepsy , with access to potentially life-changing medical treatments.

article thumbnail

Getting to Know Cannabigerol with Bonni Goldstein, MD

Project CBD

Dr. Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. Dr. Goldstein: We don’t have clinical trials to say, yes this is definitively beneficial or detrimental for children.

article thumbnail

Press Release: Danish psychiatric research hospital will study the effects of Filament’s natural psilocybin drug candidate for treating alcohol use disorder

Cannabis Law Report

Vancouver, British Columbia, January 18, 2023 – Filament Health Corp. The […]

article thumbnail

SciSparc Signs Agreement for the Supply of CBD-rich Cannabis Oil for its Clinical Trial on Children with Autism Spectrum Disorder

Medical Marijuana Program Connection

The cannabis oil will be used as a part of the Company‘s proprietary SCI-210 treatment combination of CBD and CannAmide™ TEL. Read More